Polymer and lipid excipients for drug delivery

Curapath is your trusted global CDMO partner for non-viral drug delivery programs, seamlessly supporting your journey from preclinical to commercial manufacturing. Our phase-appropriate approach ensures tailored process development and validation, alongside our extensive expertise in lipid and polymer novel excipients and nanoparticle formulations. Rely on Curapath’s precision and expertise to drive your drug delivery innovations forward.